Recent Quarter Total Invested
$3.27 B
Recent Quarter Institutional Ownership Percentage
85.88%
Total Invested of Last Quarter
$3.06 B
Ownership Percentage of Last Quarter
84.45%
Axsome Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RTW INVESTMENTS, LP | 08/14/2024 | 4.63 M | $373.06 M | 3.15% | 9.78% |
VANGUARD GROUP INC | 08/13/2024 | 3.74 M | $301.23 M | 0.05% | 7.90% |
BLACKROCK INC. | 08/13/2024 | 3.30 M | $265.65 M | 3.27% | 6.96% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2024 | 2.36 M | $189.99 M | 0.00% | 4.98% |
DEEP TRACK CAPITAL, LP | 08/14/2024 | 1.85 M | $149.15 M | 42.01% | 3.91% |
MACQUARIE GROUP LTD | 08/09/2024 | 1.07 M | $86.40 M | 53.23% | 2.26% |
RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 1.00 M | $80.50 M | 0.00% | 2.11% |
BVF INC/IL | 08/14/2024 | 955,000 | $76.88 M | 100.00% | 2.02% |
EVENTIDE ASSET MANAGEMENT, LLC | 08/13/2024 | 938,714 | $75.57 M | 170.75% | 1.98% |
STATE STREET CORP | 08/14/2024 | 938,503 | $75.55 M | -0.02% | 1.98% |
FMR LLC | 08/13/2024 | 902,136 | $72.62 M | 8.88% | 1.90% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 890,985 | $71.72 M | 379.76% | 1.88% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 884,895 | $71.25 M | 4.67% | 1.87% |
CITADEL ADVISORS LLC | 08/14/2024 | 753,237 | $60.64 M | -34.14% | 1.59% |
ALETHEA CAPITAL MANAGEMENT, LLC | 08/15/2024 | 740,888 | $59.64 M | 0.01% | 1.56% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 739,819 | $59.56 M | -0.23% | 1.56% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 734,620 | $59.14 M | 8.57% | 1.55% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 730,000 | $58.77 M | 41.75% | 1.54% |
INVESCO LTD. | 08/13/2024 | 557,861 | $44.91 M | 127.09% | 1.18% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2024 | 549,066 | $44.20 M | 5.44% | 1.16% |
BELLEVUE GROUP AG | 08/14/2024 | 516,533 | $41.58 M | -24.65% | 1.09% |
POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 479,044 | $38.56 M | 26.44% | 1.01% |
PFM HEALTH SCIENCES, LP | 08/14/2024 | 467,427 | $37.63 M | 0.00% | 0.99% |
PERCEPTIVE ADVISORS LLC | 08/16/2024 | 459,111 | $36.96 M | -58.46% | 0.97% |
NORGES BANK | 08/14/2024 | 404,217 | $32.54 M | 100.00% | 0.85% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 401,327 | $32.31 M | 37.62% | 0.85% |
BOXER CAPITAL, LLC | 08/14/2024 | 400,000 | $32.20 M | 0.00% | 0.84% |
CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 400,000 | $32.20 M | 100.00% | 0.84% |
AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 376,000 | $30.27 M | -12.76% | 0.79% |
FIRST TURN MANAGEMENT, LLC | 08/08/2024 | 337,246 | $27.15 M | -1.44% | 0.71% |
NORTHERN TRUST CORP | 08/14/2024 | 324,493 | $26.12 M | -3.45% | 0.68% |
MORGAN STANLEY | 10/17/2024 | 321,981 | $25.92 M | -65.89% | 0.68% |
WOODLINE PARTNERS LP | 08/14/2024 | 318,011 | $25.60 M | -11.70% | 0.67% |
SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 310,198 | $24.97 M | 100.00% | 0.65% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 309,818 | $24.94 M | 2.90% | 0.65% |
TRI LOCUM PARTNERS LP | 08/14/2024 | 306,513 | $24.67 M | 198.42% | 0.65% |
VESTAL POINT CAPITAL, LP | 08/14/2024 | 300,000 | $24.15 M | 100.00% | 0.63% |
CHECKPOINT CAPITAL L.P. | 08/14/2024 | 290,772 | $23.41 M | 119.56% | 0.61% |
LOOMIS SAYLES & CO L P | 08/13/2024 | 269,089 | $21.66 M | -3.83% | 0.57% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 243,000 | $19.56 M | 31.71% | 0.51% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 186,800 | $15.04 M | 18.38% | 0.39% |
JPMORGAN CHASE & CO | 08/12/2024 | 184,576 | $14.86 M | -5.47% | 0.39% |
ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 168,762 | $13.59 M | 110.55% | 0.36% |
JANE STREET GROUP, LLC | 08/15/2024 | 168,434 | $13.56 M | -15.39% | 0.36% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 165,564 | $13.33 M | 7.67% | 0.35% |
GHOST TREE CAPITAL, LLC | 08/14/2024 | 150,000 | $12.08 M | -28.57% | 0.32% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 135,855 | $10.94 M | 402.39% | 0.29% |
US BANCORP \DE\ | 08/07/2024 | 132,705 | $10.68 M | -0.60% | 0.28% |
BIOIMPACT CAPITAL LLC | 08/14/2024 | 132,312 | $10.65 M | 15.93% | 0.28% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2024 | 127,600 | $10.27 M | -11.14% | 0.27% |
Axsome Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AXSM shares?
During the previous two years, 118 institutional investors and hedge funds held shares of Axsome Therapeutics, Inc.. The most heavily invested institutionals were:
BioImpact Capital LLC: 0
XTX Topco Ltd: 0
ALGERT GLOBAL LLC: 0
Stephens Consulting, LLC: 0
Flower City Capital: 0
WMS Partners, LLC: 0
-
What percentage of Axsome Therapeutics, Inc. stock is owned by institutional investors?
85.88% of Axsome Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AXSM ?
Institutional investors have bought a total of 17.03 M shares in the last 24 months. This purchase volume represents approximately $1.58 B in transactions.